1-8 of 8
Marta Medeot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ABCG2 but Not ABCB1 RNA Levels at Diagnosis and during Treatment Correlates with Response to Imatinib and 2G-Tkis Front-Line Therapy in Chronic Phase CML Patients

Mario Tiribelli, MD, Sara Di Giusto, Eleonora Toffoletti, Davide Griguolo, Domenico Penna, Giorgia Maccari, Marta Medeot, Renato Fanin, Daniela Damiani
Journal: Blood
Blood (2017) 130 (Supplement 1): 1614.
https://doi.org/10.1182/blood.V130.Suppl_1.1614.1614
Published: 2017
Journal Articles

Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide

Brief Report
Christopher G. Kanakry, Javier Bolaños-Meade, Yvette L. Kasamon, Marianna Zahurak, Nadira Durakovic, Terry Furlong, Marco Mielcarek, Marta Medeot, Ivana Gojo, B. Douglas Smith, Jennifer A. Kanakry, Ivan M. Borrello, Robert A. Brodsky, Douglas E. Gladstone, Carol Ann Huff, William H. Matsui, Lode J. Swinnen, Kenneth R. Cooke, Richard F. Ambinder, Ephraim J. Fuchs, Marcos J. de Lima, Borje S. Andersson, Ravi Varadhan, Paul V. O’Donnell, Richard J. Jones, Leo Luznik
Journal: Blood
Blood (2017) 129 (10): 1389–1393.
https://doi.org/10.1182/blood-2016-09-737825
Published: 2017
Includes: Supplemental data
Journal Articles

Similar Efficacy of Dasatinib and Nilotinib As Second-Line Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Failing Imatinib: A Retrospective, Real-Life Study

Mario Tiribelli, MD, Massimiliano Bonifacio, Gianni Binotto, MD, Alessandra Iurlo, MD, Francesca Cibien, MD, Elena Maino, MD, Anna Guella, MD, Gianluca Festini, MD, Claudia Minotto, MD, Ercole De Biasi, MD, Federico De Marchi, MD, Luigi Scaffidi, Luca Frison, MD, Cristina Bucelli, MD, Marta Medeot, MD, Elisabetta Calistri, MD, Mauro Krampera, Filippo Gherlinzoni, MD, Gianpietro Semenzato, Achille Ambrosetti, MD, Giovanni Pizzolo, Renato Fanin
Journal: Blood
Blood (2016) 128 (22): 5434.
https://doi.org/10.1182/blood.V128.22.5434.5434
Published: 2016
Journal Articles

Allogeneic Stem Cell Transplantation Versus B-Cell-Receptor Inhibitors in 17p Deletion and/or Refractory Chronic Lymphocytic Leukemia: A Retrospective Comparative Analysis of 'Real Life' Approaches to High Risk Patients, on Behalf of Rete Ematologica Lombarda (REL) and Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Lucia Farina, MD PhD, Francesca Patriarca, Maddalena Mazzucchelli, Chiara Salvetti, MD, Giulia Quaresmini, Marta Medeot, MD, Daniele Vincenti, Gianluigi Reda, MD, Andrea Ferrario, MD, Francesco Zallio, MD, Anna Dodero, Benedetto Bruno, MD PhD, Paolo Corradini, Marco Montillo, MD
Journal: Blood
Blood (2016) 128 (22): 4695.
https://doi.org/10.1182/blood.V128.22.4695.4695
Published: 2016
Journal Articles

Predictive Factors of Stable Deep Molecular Response in Chronic Myeloid Leukemia Patients Treated with Imatinib Standard Dose: A Study from the Gruppo Triveneto LMC

Massimiliano Bonifacio, MD, Luigi Scaffidi, Gianni Binotto, Federico De Marchi, Elena Maino, Elisabetta Calistri, Angela Bonalumi, Luca Frison, Luciana Marin, Marta Medeot, Giovanna De Matteis, Renato Fanin, Gianpietro Semenzato, Achille Ambrosetti, Mario Tiribelli, MD
Journal: Blood
Blood (2015) 126 (23): 597.
https://doi.org/10.1182/blood.V126.23.597.597
Published: 2015
Journal Articles

EUTOS Score Predicts Optimal Response To Imatinib According To The Revised ELN Recommendations Better Than Sokal Score: A Study From The “Gruppo Triveneto LMC”

Mario Tiribelli, MD, Massimiliano Bonifacio, MD, Gianni Binotto, MD, Elisabetta Calistri, MD, Elena Maino, MD, Roberta Zanotti, MD, Antonio Branca, MD, Marta Medeot, MD, Gianpietro Semenzato, MD, Giovanni Pizzolo, MD, Renato Fanin, MD
Journal: Blood
Blood (2013) 122 (21): 4024.
https://doi.org/10.1182/blood.V122.21.4024.4024
Published: 2013
Journal Articles

Post-Transplantation Cyclophosphamide Following Busulfan and Fludarabine Myeloablative Conditioning Prevents Severe Acute and Chronic Graft-Versus-Host Disease and Minimizes Duration Of Immunosuppression: Results Of a Multi-Institutional Trial In Patients With High-Risk Hematologic Malignancies

Christopher G. Kanakry, MD, Paul O’Donnell, MD, PhD, Terry Furlong, NP, Marcos J de Lima, MD, Wei Wei, MS, Marta Medeot, MD, Marco Mielcarek, MD, Richard E Champlin, MD, Richard J. Jones, Peter F. Thall, PhD, Borje S. Andersson, MD, PhD, Leo Luznik
Journal: Blood
Blood (2013) 122 (21): 3310.
https://doi.org/10.1182/blood.V122.21.3310.3310
Published: 2013
Journal Articles

Brain Natriuretic Peptide (BNP) Level as Marker of Cardiac Function in Imatinib - Treated Chronic Myeloid Leukemia Patients: No Evidence of Cardiotoxicity of Imatinib Therapy.

Mario Tiribelli, MD, Antonio Colatutto, MD, Luciana Marin, MD, Eleonora Toffoletti, MD, Giuseppe Barbina, PhD, Ugo Qualizza, MD, Elio Tonutti, MD, Anna Candoni, MD, Marta Medeot, MD, Daniela Damiani, MD, Giorgio Morocutti, MD, Sala Pierguido, MD, Renato Fanin, MD
Journal: Blood
Blood (2007) 110 (11): 2948.
https://doi.org/10.1182/blood.V110.11.2948.2948
Published: 2007